Matthew Bernard, PhD
Associate Professor (Fixed-Term) and MSU Flow Cytometry Core Director
Pharmacology and Toxicology
Pharmacology and Toxicology
Research
Colleges
Associations
- MSU Flow Cytometry Core Director
Facilities
- MSU Flow Cytometry Core Facility
Funding
- Acquisition of a Brightfield Imaging Capable Flow Cytometer to Facilitate Agricultural and Environmental Research, National Institute of Food and Agriculture (2022-09-01—2026-08-31)
Works
- Effects of rumen-protected niacin on inflammatory response to repeated intramammary lipopolysaccharide challenges. Journal of Dairy Science (2024)
- Respiration is essential for aerobic growth of Zymomonas mobilis ZM4. mBio (2023-12-19)
- Interleukin-10-producing monocytes contribute to sex differences in pain resolution in mice and humans. (2023-11-05)
- Phosphatidylserine-Exposing Annexin A1-Positive Extracellular Vesicles: Potential Cancer Biomarkers. Vaccines (2023-03-13)
- Evaluation of the Efficacy and Safety of Antiplatelet Therapeutics in Rabbits. Current Protocols (2023)
- Isolation and characterization of uterine leukocytes collected from uterine swab technique. American journal of reproductive immunology (New York, N.Y. : 1989) (2022-08-23)
- Isolation and characterization of uterine leukocytes collected using a uterine swab technique. American Journal of Reproductive Immunology (2022)
- Small Molecule 20S Proteasome Enhancer Regulates MYC Protein Stability and Exhibits Antitumor Activity in Multiple Myeloma. Biomedicines (2022-04-19)
- Small Molecule 20S Proteasome Enhancer Regulates MYC Protein Stability and Exhibits Antitumor Activity in Multiple Myeloma. Biomedicines (2022)
- Phosphatidylserine-exposing medium/large extracellular vesicles: potential cancer biomarkers. bioRxiv (2022)
- In vitro and in vivo analysis of microvesicle-mediated metastasis using a bright, red-shifted bioluminescent reporter protein of extracellular vesicles. bioRxiv (2021)
- Enhancing c-MYC degradation via 20S proteasome activation induces in vivo anti-tumor efficacy. bioRxiv (2020)
- Microvesicle-Mediated Delivery of Minicircle DNA Results in Effective Gene-Directed Enzyme Prodrug Cancer Therapy. Molecular cancer therapeutics (2019-08-26)
- Microvesicle-mediated delivery of minicircle DNA results in effective gene-directed enzyme prodrug cancer therapy. Molecular Cancer Therapeutics (2019)
- DT-678 inhibits platelet activation with lower tendency for bleeding compared to existing P2Y12 antagonists. Pharmacology research & perspectives (2019-07-25)
- DT-678 inhibits platelet activation with lower tendency for bleeding compared to existing P2Y12 antagonists. Pharmacology Research and Perspectives (2019)
- Identifying chemopreventive agents for obesity-associated cancers using an efficient, 3D high-throughput transformation assay. Scientific reports (2019-07-16)
- Identifying chemopreventive agents for obesity-associated cancers using an efficient, 3D high-throughput transformation assay. Scientific Reports (2019)
- Inhibition of cyclooxygenase-2 impairs the expression of essential plasma cell transcription factors and human B-lymphocyte differentiation. Immunology (2010-01-01)
- Inhibition of cyclooxygenase-2 impairs the expression of essential plasma cell transcription factors and human B-lymphocyte differentiation. Immunology (2010)
- Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection. Vaccine (2009-11-24)
- Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection. Vaccine (2010)
- Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells. Cellular immunology (2009-04-05)
- Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells. Cellular Immunology (2009)
- Peroxisome proliferator-activated receptor γ ligands enhance human B cell antibody production and differentiation. Journal of Immunology (2009)
- Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise. Current pharmaceutical design (2008-01-01)
- Targeting cyclooxygenase-2 in hematological malignancies: Rationale and promise. Current Pharmaceutical Design (2008)
- CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production. Clinical immunology (Orlando, Fla.) (2007-08-28)
- CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: Implications for adjuvant activity and antibody production. Clinical Immunology (2007)
- Cyclooxygenase-2 inhibition attenuates antibody responses against human papillomavirus-like particles. Journal of Immunology (2006)
- Experimental validation of DNA sequences for DNA computing: Use of a SYBR green I assay. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) (2006)